The Clash of Cannabinomics and Big Pharma Medicine - Jay Taylor Interviews Dr. Christopher Glenn Fichtner
(Thomson Reuters ONE) -
Vancouver, British Columbia, June 13, 2011 - Jay Taylor, publisher of the J
Taylor's Gold, Energy & Tech Stocks newsletter, interviews Dr. Christopher Glenn
Fichtner, author of "Cannabinomics" - The Marijuana Policy Tipping Point.
Dr. Fichtner currently holds an appointment as Clinical Professor in the
Department of Psychiatry at the Southern Illinois University School of Medicine.
Since 2008, he has worked as a staff psychiatrist for the Riverside County
Department of Mental Health in Southern California.
Dr. Fichtner's book examines what happens behind the iron medical curtain when
Americans are shown how to take ownership of this homegrown commodity and
facilitate system-learning that could help solve larger global drug war
problems.
Jay will also talk to George Pirie, the new President and CEO of San Gold
Corporation (SGR.TO) (OTCQX:SGRCF), about the extraordinary potential of San
Gold. Jay Taylor believes San gold can become the next GoldCorp Inc.
Jay's weekly, two hour VoiceAmerica radio show, "Turning Hard Times into Good
Times" will be broadcast Tuesday, June 14th at 3:00PM Eastern Time and 12:00
Noon Pacific Time and can be located by clicking here or at
www.voiceamerica.com/Show/1501. It is also archived, and can be heard on
www.jaytaylormedia.com.
Jay Taylor spoke at the New York Hard Assets Investment Conference held at the
Marriott. On May 9(th), Jay's presentation was titled, "Why Gold Mining Shares
are the Buy of a Lifetime", and on May 10(th), he was joined by Chen Lin for the
workshop "Some Top Picks". These two presentations are available for viewing on
www.InvestmentPitch.com.
CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
bmorgan(at)investmentpitch.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: InvestmentPitch via Thomson Reuters ONE
[HUG#1523129]
Unternehmensinformation / Kurzprofil:
Datum: 13.06.2011 - 23:56 Uhr
Sprache: Deutsch
News-ID 55516
Anzahl Zeichen: 2483
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 189 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"The Clash of Cannabinomics and Big Pharma Medicine - Jay Taylor Interviews Dr. Christopher Glenn Fichtner"
steht unter der journalistisch-redaktionellen Verantwortung von
InvestmentPitch (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
